Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (2.864.761 €): Innovative Schulung in Methoden für zukünftige Daten Hor21.03.2017 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Innovative Schulung in Methoden für zukünftige Daten
IMforFUTURE is an innovative multidisciplinary and intersectoral research training programme which addresses current shortcomings in omics research. We aim to open the new research horizon in integration of genetics, glycomics, and epigenomics datasets into systems biology by developing innovative methods for high throughput omics and for integrative analysis of omics data. We focus on ageing, which is the biggest single risk factor for many diseases. By application of our novel methods to emerging datasets representing inflammation and immunology, IMforFUTURE will contribute to understanding of the underlying biological processes involved in diseases and ageing. To be successful in future multidisciplinary environments in Academia or Industry, ESRs need to be able to act as bridge between several diverse disciplines. Our ESRs need to overview all steps from data production via data analysis to data interpretation. In our consortium 7 academic and 4 industrial partners - experimental and theoretical - participate in research and training via teaching, offering secondments and hosting ESRs. We offer courses in high throughput methodology, genomics and statistics. Secondments will be to partners with complementary disciplines and intersectoral. Emphasis will be data management, data stewardship, entrepreneurship, and complementary skills. Interdisciplinary collaborations among ESRs will be stimulated by working on the same studies, in which new data will be generated, integrated with other datasets, analyzed with novel methods and interpreted. At the end of the project the ESRs will present and discuss their research in an integrated workshop. Our ESRs will be ready and equipped for new-generation multidisciplinary researchers. They will significantly contribute to omics research in relationship to human disease and health and knowledge translation. A conference to disseminate our work to researchers in Academia and Industry, and to stakeholders will be organized.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Academisch Ziekenhuis Leiden | 255.374 € |
| Alma Mater Studiorum - Universita DI Bologna | 516.123 € |
| 247.761 € | |
| GLYXERA GmbH | 249.216 € |
| 247.761 € | |
| King's College London | 273.288 € |
| The University of Edinburgh | 273.288 € |
| Universitair Medisch Centrum Utrecht | 255.374 € |
| University of Leeds | 546.576 € |
Quelle: https://cordis.europa.eu/project/id/721815
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
Die Visualisierungen zu "Academisch Ziekenhuis Leiden - EU-Förderung (2.864.761 €): Innovative Schulung in Methoden für zukünftige Daten"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
